New findings from Harvard Medical School reveal that Pharma industry payments to physicians in Massachusetts are associated with higher rates of prescribing brand-name drugs that treat high cholesterol. “You want your doctors to be objective rather than doing something because there is a financial gain, be it subconscious or conscious,” the lead author told ProPublica. “That’s not the way we should be doing medicine.”
